ClinicalTrials.Veeva

Menu

The Combination Effect of Platelet-rich Plasma and Hyaluronic Acid for Knee Osteoarthritis

T

Tri-Service General Hospital

Status

Completed

Conditions

Knee Osteoarthritis

Treatments

Drug: platelet rich plasma + normal saline
Drug: platelet rich plasma + Hyaluronic acid

Study type

Interventional

Funder types

Other

Identifiers

NCT03290365
PRP and HA for OA knee

Details and patient eligibility

About

Although platelet rich plasma (PRP) and Hyaluronic acid (HA) are beneficial for osteoarthritis of knee (OA knee), the combined effect of PRP with HA was not clear so far. Hence, investigator assess a prospective randomized double-blind controlled trial.

Full description

Patients with single or bilateral OA knee will be enrolled and randomized into intervention and control group. One dose of PRP is applied into both groups. One week later, one dose of HA is injected in intervention group and one dose of normal saline is injected in control group. Outcome measurements included visual analog scale (VAS)、Lequesne's severity index、Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)、balance test (Biodex) and analysis of synovial fluid at different follow-up frame (1st month, 3rd month, 6th month and 1 year after treatment).

Enrollment

46 patients

Sex

All

Ages

50 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age between 50 to 75 y/o.
  2. Alert consciousness
  3. Symptom of knee osteoarthritis persist at least 6 months and stage I to III scored by Ahlbäck grading system
  4. The pain score measured by VAS at least 4 points

Exclusion criteria

  1. Has received hyaluronic acid, PRP or steroid injection within 6 months
  2. Has received NSAIDs or steroid within one week
  3. Tumor or metastasis surrounding the knee joint
  4. Has received total knee replacement, major surgery in knee, rheumatoid arthritis
  5. Patient who cant tolerance the balance test.
  6. Thrombocytopenia or coagulopathy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

46 participants in 2 patient groups, including a placebo group

Platelet rich plasma + Hyaluronic acid
Active Comparator group
Description:
Platelet rich plasma (PRP) and Hyaluronic acid (HA) are beneficial for patients with osteoarthritis of knee. Patients received one dose of PRP injection. One week later, the one dose of HA is injected for intervention group.
Treatment:
Drug: platelet rich plasma + Hyaluronic acid
Platelet rich plasma + normal saline
Placebo Comparator group
Description:
Patients received one dose of PRP injection. One week later, the one dose of normal saline is injected for control group.
Treatment:
Drug: platelet rich plasma + normal saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems